author-photo

Nikolaus S. Trede

Celgene

3

Papers

12

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in 3 Ongoing Clinical Studies in Relapsed/Refractory (R/R) Large B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Noneligible (TNE) Patients: Transcend NHL 001, Outreach, and PILOT

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (3)
Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT

2019 Blood
Show All
- Source
- Cite
- Save
Citations (9)